Physician profile
Beth Mccoy
NPI 1285089375
$1,568.39
in general payments reported to CMS, 2019-2025
18 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $321 · 2022: $339 · 2023: $265 · 2024: $306 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $908.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $689.28 | 2021-2025 | |
| Glaxosmithkline, LLC. | $155.08 | 2021-2023 | Trelegy Ellipta |
| Lilly USA, LLC | $125.88 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $88.43 | 2024-2025 | Caplyta |
| Axsome Therapeutics, INC. | $81.93 | 2025 | Auvelity |
| Pfizer INC. | $68.51 | 2023-2025 | |
| Novo Nordisk INC | $53.47 | 2022-2023 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $52.62 | 2021 | |
| Exact Sciences Corporation | $44.67 | 2023-2025 | Cologuard Collection Kit |
| Indivior INC. | $37.92 | 2025 | Sublocade |
| Amgen INC. | $28.29 | 2021 | |
| Alkermes, INC. | $27.99 | 2021-2025 | Lybalvi |
| Abbott Laboratories | $22.89 | 2021 | |
| Braeburn INC. | $19.77 | 2024 | Brixadi |
| Otsuka America Pharmaceutical, INC. | $19.03 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $18.44 | 2024 | Voquezna |
| Vanda Pharmaceuticals INC. | $18.08 | 2025 | Fanapt |
| Azurity Pharmaceuticals, INC. | $16.11 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Mccoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.